Over 150 New York Auctions End Today - Bid Now
Over 1350 Total Lots Up For Auction at Three Locations - NJ 04/25, MA 04/30, NJ Cleansweep 05/02

Mike Kaufmann

Cardinal Health names new CEO
November 10, 2017
Business Affairs
DUBLIN, Ohio, Nov. 6, 2017 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has named Mike Kaufmann, 54, its current chief financial officer, to serve as the company's next chief executive officer and join the board of directors, effective Jan. 1, 2018. Kaufmann will succeed George Barrett, 62, Cardinal Health's chairman and chief executive officer since 2009, who will continue to serve as executive chairman of the board of directors through the annual meeting of shareholders in November 2018. At that time, Gregory Kenny, Cardinal Health's lead independent director, will assume the role of non-executive chairman.

Kaufmann is a 27-year veteran of Cardinal Health with responsibility for all of the company's financial activities in addition to overseeing Global Sourcing for both the Pharmaceutical and Medical segments. As a member of Cardinal Health's senior executive team, Kaufmann has played an important role in developing and executing the company's strategy. He has also been instrumental in key strategic initiatives, including the company's joint venture with CVS Health, Red Oak Sourcing, where he serves on the board of directors, and the creation of Fuse, Cardinal Health's technology innovation center. He previously held senior commercial and operational leadership positions across the Pharmaceutical and Medical businesses.

Lead Director Kenny said, "A critical responsibility of our board of directors is thoughtful succession planning. We have worked closely with George throughout his tenure on this important process and, under his stewardship, Cardinal Health has developed a strong leadership bench. In appointing Mike as our next CEO, the board has chosen a proven executive with demonstrated leadership skills and deep operational experience. Mike has broad knowledge across key areas of Cardinal Health's operations and excellent relationships with our customers, our business partners, and the financial community. We are confident that he has the talents and abilities to lead Cardinal Health through our next stage of growth, and we expect a very smooth transition of leadership."

Kenny continued, "In determining the board's governance structure announced today, we have taken into account a wide range of factors, including the current practices of other organizations, as well as the views of our shareholders. The board will continue to evaluate this structure on a regular basis in service to its shareholders and other key stakeholders."

You Must Be Logged In To Post A Comment

 

advertisement

Business Affairs Homepage

Five ways to increase clinical trial diversity through patient engagement
Insights from Catherine Ofori-Atta, senior clinical operations lead at Roche and Sandra Amaro, head of clinical trial diversity at Pfizer
Cardiologist who billed 28 hours of exams in a single day cops to fraud
New Jersey provider admits to almost $2 million in phony claims
ACR cuts workforce 11% citing pandemic impact
45 employees were affected by the downsizing
GE HealthCare's imaging CEO stepping down
Jan Makela will be leaving after more than 17 years with the company
Connecticut patient to receive $14 million after table collapses during imaging exam
Incident took place in 2014 and legal battle began in 2016
Understanding healthcare's big shift toward outpatient facilities from a real estate perspective
New report from JLL sheds light on motives and advantages
STERIS to divest its dental segment to Peak Rock Capital for $787 million
Sale allows company to focus on core markets including healthcare, pharmaceuticals, and medtech
Massive Stark Law settlement underscores continued government scrutiny of health system physician employment arrangements
Insights from Joseph Keillor, healthcare attorney with Baker Donelson
RadNet expands Houston presence with acquisition of six imaging centers
Will rebrand them under the Houston Medical Imaging banner
KARL STORZ enters talks to acquire Asensus Surgical for $95 million
Surgical robot developer is a pioneer in digitizing surgical procedures